OncLive® On Air

Jhaveri on the INAVO120 Trial of Inavolisib/Palbociclib/Fulvestrant in PIK3CA -Mutant, HR+ Breast Cancer

Season 11, Episode 5, Aug 22, 08:35 PM

Headliner

Embed Code See more options

Dr Jhaveri discusses the INAVO120 trial of inavolisib plus palbociclib and fulvestrant in PIK3CA-mutant, HR-positive metastatic breast cancer.

Audioboom uses Javascript

Please enable it in your browser's preferences.

You can visit our support center if you're having problems.

Sorry, your browser isn't supported by Audioboom.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

You can visit our support center if you're having problems.